Iekuni Oh

2.9k total citations · 1 hit paper
58 papers, 1.8k citations indexed

About

Iekuni Oh is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Iekuni Oh has authored 58 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 18 papers in Genetics and 15 papers in Immunology. Recurrent topics in Iekuni Oh's work include Acute Myeloid Leukemia Research (14 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Immune Cell Function and Interaction (9 papers). Iekuni Oh is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Immune Cell Function and Interaction (9 papers). Iekuni Oh collaborates with scholars based in Japan, United States and South Korea. Iekuni Oh's co-authors include Kazuya Sato, William H. Harris, Katsutoshi Ozaki, Keiya Ozawa, Kazuo Muroi, Akiko Meguro, Tadashi Nagai, Keiko Hatanaka, Raine Tatara and Kaoru Hatano and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Iekuni Oh

56 papers receiving 1.8k citations

Hit Papers

Nitric oxide plays a critical role in suppression of T-ce... 2006 2026 2012 2019 2006 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iekuni Oh Japan 15 852 630 434 411 364 58 1.8k
Kazuya Sato Japan 17 951 1.1× 483 0.8× 533 1.2× 423 1.0× 410 1.1× 78 2.0k
Katarina LeBlanc Sweden 16 1.0k 1.2× 471 0.7× 380 0.9× 339 0.8× 229 0.6× 21 1.6k
Lena von Bahr Sweden 10 1.2k 1.4× 591 0.9× 442 1.0× 289 0.7× 269 0.7× 14 1.6k
Eva Zetterberg Sweden 15 1.3k 1.6× 704 1.1× 470 1.1× 457 1.1× 244 0.7× 51 2.0k
Yukari Muguruma Japan 17 838 1.0× 430 0.7× 724 1.7× 496 1.2× 272 0.7× 28 1.7k
Sandrine Bouchet France 16 994 1.2× 451 0.7× 448 1.0× 246 0.6× 292 0.8× 31 1.7k
Attila Szakos Sweden 11 1.0k 1.2× 515 0.8× 353 0.8× 357 0.9× 212 0.6× 20 1.6k
Ellie G.A. Lurvink Netherlands 7 1.0k 1.2× 449 0.7× 330 0.8× 350 0.9× 513 1.4× 9 1.5k
Sadafumi Suzuki Japan 16 799 0.9× 394 0.6× 723 1.7× 352 0.9× 370 1.0× 28 1.9k
Steve Devine United States 13 1.7k 2.0× 738 1.2× 481 1.1× 516 1.3× 325 0.9× 22 2.3k

Countries citing papers authored by Iekuni Oh

Since Specialization
Citations

This map shows the geographic impact of Iekuni Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iekuni Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iekuni Oh more than expected).

Fields of papers citing papers by Iekuni Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iekuni Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iekuni Oh. The network helps show where Iekuni Oh may publish in the future.

Co-authorship network of co-authors of Iekuni Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Iekuni Oh. A scholar is included among the top collaborators of Iekuni Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iekuni Oh. Iekuni Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mashima, Kiyomi, Iekuni Oh, Ken Fujiwara, et al.. (2021). Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models. PLoS ONE. 16(1). e0245232–e0245232. 6 indexed citations
3.
Ito, Shoko, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2019). Evaluation of thrombotic events in patients with immune thrombocytopenia. Annals of Hematology. 99(1). 49–55. 14 indexed citations
4.
Umino, Kento, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2018). Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement. Hematology. 23(8). 470–477. 20 indexed citations
5.
Kawasaki, Yasufumi, Kazuya Sato, Hiroko Hayakawa, et al.. (2018). Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 24(8). 1563–1574. 24 indexed citations
6.
Mashima, Kiyomi, Iekuni Oh, Takashi Ikeda, et al.. (2018). Role of Sequential Monitoring of WT1 Gene Expression in Patients With Acute Myeloid Leukemia for the Early Detection of Leukemia Relapse. Clinical Lymphoma Myeloma & Leukemia. 18(12). e521–e527. 12 indexed citations
7.
Ito, Shoko, Shin‐ichiro Fujiwara, Kiyomi Mashima, et al.. (2017). Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia. Annals of Hematology. 96(5). 719–724. 9 indexed citations
8.
Umino, Kento, Shin‐ichiro Fujiwara, Kazuya Sato, et al.. (2017). High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement. Acta Haematologica. 137(2). 93–99. 3 indexed citations
11.
Muroi, Kazuo, Shin‐ichiro Fujiwara, Raine Tatara, et al.. (2013). CD56 Expression in Normal Immature Granulocytes after Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Clinical and Experimental Hematopathology. 53(3). 247–250. 6 indexed citations
12.
Oka, Satoko, Kazuo Muroi, Kazuya Sato, et al.. (2012). Flow Cytometric Analysis of Kappa and Lambda Light Chain Expression in Endoscopic Biopsy Specimens before the Diagnosis of B-Cell Lymphoma. Journal of Clinical and Experimental Hematopathology. 52(2). 127–131. 4 indexed citations
13.
Meguro, Akiko, Katsutoshi Ozaki, Keiko Hatanaka, et al.. (2011). Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells. Bone Marrow Transplantation. 46(12). 1557–1565. 10 indexed citations
14.
Tatara, Raine, Katsutoshi Ozaki, Yuji Kikuchi, et al.. (2010). Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation. Cytotherapy. 13(6). 686–694. 75 indexed citations
15.
Sato, Kazuya, Katsutoshi Ozaki, Shin‐ichiro Fujiwara, et al.. (2010). Incidental carcinomas detected by PET/CT scans in patients with malignant lymphoma. International Journal of Hematology. 92(4). 647–650. 13 indexed citations
16.
Meguro, Akiko, Katsutoshi Ozaki, Iekuni Oh, et al.. (2009). IL-21 is critical for GVHD in a mouse model. Bone Marrow Transplantation. 45(4). 723–729. 22 indexed citations
17.
Ozawa, Keiya, Kazuya Sato, Iekuni Oh, et al.. (2008). Cell and gene therapy using mesenchymal stem cells (MSCs). Journal of Autoimmunity. 30(3). 121–127. 127 indexed citations
18.
Hatano, Kaoru, Jiro Kikuchi, Masaaki Takatoku, et al.. (2008). Bortezomib Overcomes Cell Adhesion-Mediated Drug Resistance Via Down-Regulation of VLA-4 Expression in Multiple Myeloma.. Blood. 112(11). 1634–1634. 2 indexed citations
19.
Oh, Iekuni, Katsutoshi Ozaki, Kazuya Sato, et al.. (2007). Interferon-γ and NF-κB mediate nitric oxide production by mesenchymal stromal cells. Biochemical and Biophysical Research Communications. 355(4). 956–962. 32 indexed citations
20.
Oh, Iekuni. (1983). A comprehensive analysis of the factors affecting acetabular cup fixation and design in total hip replacement arthroplasty: a series of experimental and clinical studies.. PubMed. 129–77. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026